» Articles » PMID: 19880463

The STAR*D Trial: Revealing the Need for Better Treatments

Overview
Journal Psychiatr Serv
Specialty Psychiatry
Date 2009 Nov 3
PMID 19880463
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

STAR*D (Sequenced Treatment Alternatives to Relieve Depression) continues to stimulate debate. The landmark trial demonstrated the feasibility of large-scale, community-based studies conducted without pharmaceutical company support. The results provided insight into nonresponse to initial treatment with selective serotonin reuptake inhibitors and alternatives for second- and third-line treatment options and suggested opportunities for personalized approaches to depression care. However, initial and one-year remission rates (28% and 70%, respectively) suggest that important goals for treatment of this disabling disease remain out of reach and that the bar for antidepressants has been set far too low.

Citing Articles

Dorsal raphe dopaminergic neurons target CaMKII neurons in dorsal bed nucleus of the stria terminalis for mediating depression-related behaviors.

Wang W, Wang D, Zhao D, Xu L, Jiang S, Zhang Y Transl Psychiatry. 2024; 14(1):408.

PMID: 39358336 PMC: 11447211. DOI: 10.1038/s41398-024-03093-6.


Facilitating Thought Progression to Reduce Depressive Symptoms: Randomized Controlled Trial.

Yatziv S, Pedrelli P, Baror S, DeCaro S, Shachar N, Sofer B J Med Internet Res. 2024; 26:e56201.

PMID: 39350528 PMC: 11582484. DOI: 10.2196/56201.


Vitamin-mediated interaction between the gut microbiome and mitochondria in depression: A systematic review-based integrated perspective.

Bisle E, Varadarajan S, Kolassa I Brain Behav Immun Health. 2024; 38:100790.

PMID: 38974216 PMC: 11225645. DOI: 10.1016/j.bbih.2024.100790.


What are the treatment remission, response and extent of improvement rates after up to four trials of antidepressant therapies in real-world depressed patients? A reanalysis of the STAR*D study's patient-level data with fidelity to the original....

Pigott H, Kim T, Xu C, Kirsch I, Amsterdam J BMJ Open. 2023; 13(7):e063095.

PMID: 37491091 PMC: 10373710. DOI: 10.1136/bmjopen-2022-063095.


Exploring the Prevalence and Factors Influencing Clinical Trial Awareness in US Adults with Self-Reported Depression and Anxiety.

Sanusi I, Arisoyin A, Aruoture S, Folorunsho I, Okereke O, Adeyemo D Cureus. 2023; 15(6):e40780.

PMID: 37485134 PMC: 10362504. DOI: 10.7759/cureus.40780.